• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

ophthalmology

Pharma

Viatris aims to be global eye care leader

After two years of getting on its feet, Viatris is making moves to grow in ophthalmology, with aims to pull down $1 billion in eye care sales by 2028.
Zoey Becker Jan 12, 2023 2:42pm

Bausch + Lomb, GRF team for 'Screen, Protect, Cure' campaign

Jan 4, 2023 9:20am

Novartis sells 5 eye drugs for up to $175M

Dec 14, 2022 11:37am

Apellis' closely watched eye drug gets new FDA goal date

Nov 18, 2022 12:03pm

Novartis targets eye, respiratory units for sell-offs: Bloomberg

Nov 16, 2022 10:48am

Viatris enters ophthalmology arena with Oyster Point buyout

Nov 7, 2022 11:58am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy